Related Articles
Non‑pegylated liposomal doxorubicin for patients with recurrent ovarian cancer: A multicentric phase II trial
Pegylated liposomal doxorubicin for platinum-resistant or refractory Müllerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of Fallopian tube and peritoneal carcinoma): A single-institutional experience
Weekly pegylated liposomal doxorubicin and paclitaxel in patients with metastatic breast carcinoma: A phase II study
Skin toxicity in a patient with ovarian cancer treated with pegylated liposomal doxorubicin: A case report and review of the literature
Combination of irinotecan and platinum for platinum-resistant or refractory recurrent ovarian cancers: A preliminary case series